BMRN · NASDAQ · Biotechnology

BioMarin (BMRN)

Develops rare-disease medicines across enzyme therapies, metabolic disorders, and skeletal conditions.

$63.86
After hours+0.49 (+0.77%)
At close$63.37(−1.08%)